High Specific Absorption Rate Research Articles

Hyaluronic acid-coated iron oxide nanoparticles for magnetic fluid hyperthermia and methylene blue dye removal: Preparation, physicochemical characterization, and enhancing the heating efficiency

We report here the magnetic fluid hyperthermia properties of water-dispersible hyaluronic acid-coated superparamagnetic iron oxide nanoparticles (HA-MNPs), prepared using the coprecipitation technique followed by ligand exchange. The presence of the hyaluronic acid coating is confirmed using Fourier transform infrared spectroscopy. Magneto-calorimetric studies show good field-induced heating efficiency of the HA-MNPs, where a high specific absorption rate (SAR) of ∼ 315 W/gFe is obtained for ∼ 5 wt% MNP concentration when exposed to an alternating magnetic field amplitude of ∼ 33.1 kA/m at ∼ 126 kHz. The heating efficiency is found to decrease by ∼ 33.8 % after immobilization of the MNPs within an agar matrix, which is attributed to the abrogation of Brownian relaxation. When subjected to an external DC magnetic field, the MNPs form linear chain-like structures, which causes the effective anisotropy energy density to increase. Magneto-calorimetric studies on agar-based oriented samples reveal a ∼ 19.5 % enhancement in SAR, thereby partly compensating for the loss in heating efficiency due to an increase in medium viscosity. The orientational ordering-induced enhancement in SAR is also verified using sweeping rate modified Stoner-Wohlfarth model-based calculations. In vitro cyto-toxicity studies on the HeLa cell lines reveal good cyto-compatibility of the MNPs. The negative charge on the surface of HA-coated MNPs is exploited to remove the cationic methylene blue dye from the aqueous medium, where the dye molecules are found to be physisorbed on the surface of the MNPs. The experimental findings clearly show the high induction heating efficiency, cyto-compatibility, and cationic dye-adsorption efficiency of the prepared HA-MNPs, thereby indicating the suitability of these MNPs for multi-functional applications like magnetic fluid hyperthermia and waste-water purification.

Optimizing the magnetic field strength and concentration of silica coated cobalt ferrite nanoparticles for magnetic hyperthermia

A therapeutic breakthrough in cancer treatment has recently been made by using magnetic nanoparticles (MNPs) for heating in hyperthermia therapy. Unapproachable tumors are being effectively destroyed by focused heat produced by MNPs. The major challenges regarding practical application of this therapy include the control and improvement of induction heating ability of MNPs and hyperthermia temperature range between 42–47 °C, for secure treatment at targeted area. Here, in this study, we have reported the synthesis and characterization of core–shell structured silica-coated cobalt ferrite nanoparticles (SiO2 coated CoFe2O4 MNPs), which are potential candidates for use as heat source in magnetic hyperthermia therapy. The SiO2 coated CoFe2O4 MNPs were synthesized using the reverse micelle method, with the SiO2 coating performed simultaneously during MNP synthesis. Various analytical tools were utilized for the characterization. The structural measurements were probed by X-ray diffraction (XRD). Monodisperse MNPs with nearly spherical core–shell structure was revealed by Transmission electron microscopy (TEM) results. The average diameter of MNPs obtained from TEM analysis was 15 nm. The surface coating of cobalt ferrite MNPs with silica was verified by Fourier transform infrared spectrometry (FTIR). The saturation magnetization values obtained using vibrating sample magnetometer (VSM) measurements were 45.74 emu/g, revealing the superparamagnetic nature of the nanoparticles. The heating efficiency of different concentrations of synthesized nanoparticles was evaluated in an aqueous solution under an alternating magnetic field of strength 5.5 kA/m at a frequency of 260 kHz. A saturation temperature of 42 °C was attained at an optimum concentration of 1.7 mg/mL, while a magnetic field strength of 3.9 kA/m achieved 42 °C at a fixed concentration of 3.5 mg/ml. The obtained specific absorption rate (SAR) values for all the samples were between 56.23 to 100.1 W/g. The correlation between SAR values, MNP concentration, and applied magnetic field strength was also examined. The high saturation magnetization, efficient heating rates, and high SAR values make our synthesized silica-coated cobalt ferrite nanoparticles promising candidates for magnetic hyperthermia treatments, potentially improving therapeutic outcomes for cancer patients.

Tailoring the Magnetic and Hyperthermic Properties of Biphase Iron Oxide Nanocubes through Post-Annealing

Tailoring the magnetic properties of iron oxide nanosystems is essential to expanding their biomedical applications. In this study, 34 nm iron oxide nanocubes with two phases consisting of Fe3O4 and α-Fe2O3 were annealed for 2 h in the presence of O2, N2, He, and Ar to tune the respective phase volume fractions and control their magnetic properties. X-ray diffraction and magnetic measurements were carried out post-treatment to evaluate changes in the treated samples compared to the as-prepared samples, showing an enhancement of the α-Fe2O3 phase in the samples annealed with O2 while the others indicated a Fe3O4 enhancement. Furthermore, the latter samples indicated enhancements in crystallinity and saturation magnetization, while coercivity enhancements were the most significant in samples annealed with O2, resulting in the highest specific absorption rates (of up to 1000 W/g) in all the applied fields of 800, 600, and 400 Oe in agar during magnetic hyperthermia measurements. The general enhancement of the specific absorption rate post-annealing underscores the importance of the annealing atmosphere in the enhancement of the magnetic and structural properties of nanostructures.

Graphene oxide decorated with MnxCo1-xFe2O4 nanoparticles for highly efficiency magnetic hyperthermia

Based on the fact that tumor cells are more thermolabile and less oxygen resistant than normal cells, a novel minimally invasive tumor treatment modality, magnetic hyperthermia (MHT) is proposed. However, magnetic materials, which are necessities in MHT, are toxic to human tissue if they are excessively employed. Thus, magnetic materials with higher specific absorption rate (SAR) and intrinsic loss power (ILP) values becomes imperative to minimize their clinical application while mitigating damage to normal human tissues under identical treatment temperature conditions. In this study, the incorporation of soft magnetic MnFe2O4 into hard magnetic CoFe2O4 was introduced, leveraging the exchange coupling between these materials to enhance the magnetic saturation (Ms). Subsequently, we combined these magnetic nanomaterials with graphene oxide (GO) to establish an efficient heat conduction pathway, further augmenting the specific absorption rate (SAR) value of the resulting magnetic composites. Our findings reveal that the Mn0.5Co0.5Fe2O4-1%GO composite developed in this investigation boasts superior SAR values and intrinsic loss power (ILP) of 49.7 W/g and 5.90 nHm2/kg, respectively, when compared to other magnetic materials. The nanomaterials synthesized in this study have the potential to significantly enhance the effectiveness of tumor magnetothermal therapy.

Effect of surgical modification of deep brain stimulation lead trajectories on radiofrequency heating during MRI at 3T: from phantom experiments to clinical implementation.

Radiofrequency (RF) tissue heating around deep brain stimulation (DBS) leads is a well-known safety risk during MRI, resulting in strict imaging guidelines and limited allowable protocols. The implanted lead's trajectory and orientation with respect to the MRI electric fields contribute to variations in the magnitude of RF heating across patients. Currently, there are no surgical requirements for implanting the extracranial portion of the DBS lead, resulting in substantial variations in clinical lead trajectories and consequently RF heating. Recent studies have shown that incorporating concentric loops in the extracranial lead trajectory can reduce RF heating. However, optimal positioning of the loops and the quantitative benefit of trajectory modification in terms of added safety margins during MRI remain unknown. In this study, the authors systematically evaluated the characteristics of DBS lead trajectories that minimize RF heating during 3T MRI to develop the best surgical practices for safe access to postoperative MRI, and they present the first surgical implementation of these modified trajectories. The authors performed experiments to assess the maximum temperature increase of 244 distinct lead trajectories. They investigated the effect of the position, number, and size of the concentric loops on the skull. Experiments were performed in an anthropomorphic phantom implanted with a commercial DBS system, and RF exposure was generated by applying a high specific absorption rate sequence (B1+rms = 2.7 µT). The authors conducted test-retest experiments to assess the reliability of measurements. Additionally, they evaluated the effect of imaging landmarks and perturbations to the DBS device configuration on the efficacy of low-heating trajectories. Finally, two neurosurgeons implanted the recommended modified trajectories in patients, and the authors characterized their RF heating in comparison with unmodified trajectories. The maximum temperature increase ranged from 0.09°C to 7.34°C. The authors found that increasing the number of loops and positioning them closer to the surgical burr hole, particularly for the contralateral lead, substantially reduced RF heating. These trajectory modifications were easily incorporated during the surgical procedure and resulted in a threefold reduction in RF heating. Surgically modifying the extracranial portion of the DBS lead trajectory can substantially reduce RF heating during 3T MRI. The authors' results indicate that simple adjustments to the lead's configuration, such as small, concentric loops near the burr hole, can be readily adopted during DBS lead implantation to improve patient safety during MRI.

Synthesis, physico-chemical properties, and AC induction heating of polycaprolactone-coated bio-compatible Fe3O4 nanoparticles

Ex-situ functionalization of Fe3O4 nanoparticles, synthesized using a coprecipitation method, with bio-compatible polycaprolactone (PCL) polymer is reported in this study. The formation of the crystalline structure of Fe3O4 is confirmed from the X-ray diffraction patterns. The presence of the PCL polymer on the surface of the coated MNPs is confirmed using Fourier transform infrared and X-ray photoelectron spectroscopy techniques and thermogravimetric analysis. Scanning and transmission electron microscopy imaging studies reveal the nearly spherical morphology of the synthesized nanoparticles. Room temperature magnetization measurements show the superparamagnetic nature of the PCL coated nanoparticles with high saturation magnetizations varying from ∼61–66 emu/g. Further, the room temperature coercivity is found to be reduced by ∼78 % for the PCL coated nanoparticles, which is attributed to the lowering of the interparticle interactions upon surface functionalization. Magnetic fluid hyperthermia studies on the PCL coated nanoparticles dispersed in ∼1 wt% agar gel shows significant alternating magnetic field induced heating efficiency, with temperature rise in the vicinity of the hyperthermia limit (∼42 °C). The highest specific absorption rate is found to be ∼85.4 ± 3.9 W/gFe, indicating an intrinsic loss power of ∼0.62 nHm2kg−1, which is significantly higher than the previously reported values for PCL coated Fe3O4 MNPs. The field induced heating efficiency is found to be correlated with the saturation magnetization of the PCL coated nanoparticles. In vitro cytotoxicity studies on human breast cancer (MCF-7) cell lines confirm the superior bio-compatibility of the PCL coated Fe3O4 nanoparticles. Superior field induced heating efficiency, coupled with good bio-compatibility makes the PCL functionalized Fe3O4 nanoparticles a potential candidate for magnetic fluid hyperthermia.

Superparamagnetic iron oxide nanoparticles functionalized by biocompatible ligands with enhanced high specific absorption rate for magnetic hyperthermia

This study introduces a novel green nanocomposite system of iron oxide coated with secondary metabolites (Fe3O4@SM) and compares it with commonly used materials for hyperthermia cancer treatment. Fe3O4@SM magnetic nanoparticles were synthesized through a simple co-precipitation process using metal precursors, followed by heating in pressure reactor to obtain superparamagnetic nanoparticles (Hc = 36.5–54.1 Oe at 300 K). These nanoparticles were subsequently coated with plant-based phytochemicals. XRD analysis confirmed the presence of magnetite iron oxide nanoparticles. SEM images further confirmed the spherical shape of the synthesized nanoparticles, exhibiting a face-centered cubic (FCC) iron oxide structure with sizes ranging from 12±7–85±15 nm. Characterization through dynamic light scattering (DLS) and zeta potential (ζ) analysis demonstrated colloidal stability, with a polydispersity index (PDI) ranging from 0.226 to 0.436 and zeta potential values ranging from −29.761–1.85 mV. The surface of the nanoparticles was analyzed using GC-MS, which identified bioactive functional groups including ester (42.79 %), terpene (20.69 %), hydrocarbons (17.4 %), and carboxylic (12.37 %) compounds. Compared to Fe3O4 and Fe3O4@GO, Fe3O4@SM exhibited a higher rate of temperature increase within the therapeutic range, reaching Tmax = 45°C with a heating rate (dT/dt) of 0.273 °C/s and specific absorption rate (SAR) of 230.6 W/g at 304 kHz and 400 Oe. In vitro assays utilizing a triple negative breast cancer microenvironment confirmed the non-toxicity of these materials through a DNS assay. The developed nanoparticles offer dual mechanisms of action, combining thermal and chemo effects, making them promising candidates for hyperthermia cancer treatment.

Induction heating of magnetic nanoparticles: role of thermo-physical properties of the coating moieties

Superparamagnetic nanoparticles (MNPs) are utilized for magnetic fluid hyperthermia (MFH)-based cancer therapeutics, where the MNPs are surface functionalized to impart desired stability and biological properties. In this study, the MFH properties of palmitic (PA) and stearic (SA) acid-coated superparamagnetic Fe3O4 MNPs, with similar sizes (∼ 10 ± 0.8 nm, and ∼ 11 ± 0.7 nm, respectively), and saturation magnetizations (∼ 40.8 emu/g, and ∼ 41 emu/g, respectively), are systematically probed to understand the role of the thermo-physical properties of the coating moieties on the MFH efficiency. PA and SA-coated MNPs are prepared using a one-step microwave-assisted co-precipitation technique, and the presence of the surface coatings is confirmed using Fourier transform infrared spectroscopy and thermogravimetric analyses. Magneto-calorimetric studies show a high induction heating efficiency, surpassing the threshold of MFH for a biologically relevant field-frequency range. The maximum heating efficiencies are found to be ∼ 164.5 ± 5.4 W/gFe and ∼ 223.9 ± 6.4 W/gFe for the PA and SA-coated MNPs, respectively. This indicates ∼ 36.1 % higher specific absorption rate (SAR) for the SA-coated MNPs under similar experimental conditions, even though the magneto-structural properties are identical for the PA and SA-coated MNPs. Further, finite element modelling is utilized to investigate the thermal transport from the magnetic core to the surrounding medium, where the thermo-physical properties of the coating moieties are considered. Finite element simulations indicate ∼ 32.6 % higher SAR for the SA-coated MNPs, which is consistent with the experimental findings. The higher SAR for the SA-coated MNPs is attributed to the ∼ 1.7 times higher thermal diffusivity of SA. The proposed model is experimentally validated using a third system consisting of lauric acid-coated Fe3O4 MNPs with comparable magneto-structural properties. Further, significant temperature rise in a tissue-equivalent agar medium and good bio-compatibility, as indicated by the in vitro cyto-toxicity studies, make the prepared MNPs potential candidates for MFH applications. The obtained results provide deeper insight into the role of the thermo-physical properties of the coating moieties on the induction heating efficiency of superparamagnetic MNPs.

Engineering Magnetic Nanoclusters for Highly Efficient Heating in Radio-Frequency Nanowarming.

Effective thawing of cryopreserved samples requires rapid and uniform heating. This is achievable through nanowarming, an approach that heats magnetic nanoparticles by using alternating magnetic fields. Here we demonstrate the synthesis and surface modification of magnetic nanoclusters for efficient nanowarming. Magnetite (Fe3O4) nanoclusters with an optimal diameter of 58 nm exhibit a high specific absorption rate of 1499 W/g Fe under an alternating magnetic field at 43 kA/m and 413 kHz, more than twice that of commercial iron oxide cores used in prior nanowarming studies. Surface modification with a permeable resorcinol-formaldehyde resin (RFR) polymer layer significantly enhances their colloidal stability in complex cryoprotective solutions, while maintaining their excellent heating capacity. The Fe3O4@RFR nanoparticles achieved a high average heating rate of 175 °C/min in cryopreserved samples at a concentration of 10 mg Fe/mL and were successfully applied in nanowarming porcine iliac arteries, highlighting their potential for enhancing the efficacy of cryopreservation.

Induced saturation transfer recovery steady states (iSTRESS) for proton exchange rate mapping with CEST MRI, a preliminary study

Proton exchange underpins essential mechanisms in diverse MR imaging contrasts. Omega plots have proven effective in mapping proton exchange rates (kex) in live human brains, enabling the differentiation of MS lesion activities and characterization of ischemic stroke. However, Omega plots require extended saturation durations (typically 5 to 10 s), resulting in high specific absorption rates (SAR) that can hinder clinical feasibility. In this study, we introduce a novel kex mapping approach, named induced Saturation Transfer Recovery Steady-States (iSTRESS). iSTRESS integrates an excitation flip angle pulse prior to chemical exchange saturation transfer (CEST) saturation, effectively aligning the magnetization with its steady-state value. This innovation reduces saturation times and mitigates SAR concerns. The formula for iSTRESS-based kex quantification was derived theoretically, involving two measurements with distinct excitation flip angles and saturation B1 values. Bloch-McConnell simulations confirmed that iSTRESS-based kex values closely matched input values (R2 > 0.99). An iSTRESS MRI sequence was implemented on a 9.4 T preclinical MRI, imaging protein phantoms with pH values ranging from 6.2 to 7.4 (n = 4). Z-spectra were acquired using excitation flip angles of 30° and 60°, followed by CEST saturation at powers of 30 and 120 Hz respectively, with a total saturation time of <1 s, resulting in two iSTRESS states for kex mapping. kex maps derived from the phantom study exhibited a linear correlation (R2 > 0.99) with Omega plot results. The developed iSTRESS method allows for kex quantification with significantly reduced saturation times, effectively minimizing SAR concerns.

A magnetic cross-linked alginate-biobased nanocomposite with anticancer and hyperthermia activities

This research study focuses on a new magnetic nanobiocomposite designed and synthesized by the formation of cross-linked alginate (Alg) hydrogel using CaCl2 cross-linker agent, its modification with flaxseed mucilage hydrogel and silk fibroin (SF) biopolymer extracted, and as well, the in-situ synthesis of Fe3O4 magnetic nanoparticles (Fe3O4 MNPs) in the presence of this biopolymeric substrate. FT-IR, EDX, FE-SEM, XRD, VSM, and TG technical analyses clarified the physical and chemical features of magnetic cross-linked Alg/flaxseed mucilage hydrogel/SF nanobiocomposite. Following the structural characterization of this magnetic natural-based composition, the in-vitro cytotoxicity and hemolysis assay studies with different concentrations resulted in prominent biological outcomes. The survival rates of normal HEK293T cells (95.74%, 94.18%) and breast cancer BT549 cells (79.23%, 77.76%) after 48 and 72 h verified the biocompatibility and anticancer properties of this new nanobiocomposite. Also, less than 5% of the hemolytic effect disclosed its hemocompatibility. Furthermore, a high specific absorption rate value (72.42 W/g) is generated by 1 mg/mL of this magnetic nanobiocomposite. Overall, it can be deduced that magnetic responsive cross-linked Alg/flaxseed mucilage hydrogel/SF nanobiocomposite could functionally perform in magnetic hyperthermia treatment.

A nudge over the relaxation plateau: effect of pH, particle concentration, and medium viscosity on the AC induction heating efficiency of biocompatible chitosan-coated Fe3O4 nanoparticles

The effects of pH, MNP concentration, and medium viscosity on the magnetic fluid hyperthermia (MFH) properties of chitosan-coated superparamagnetic Fe3O4 nanoparticles (MNPs) are probed here. Due to the protonation of the amide groups, the MNPs are colloidally stable at lower pH (∼2), but form aggregates at higher pH (∼8). The increased aggregate size at higher pH causes the Brownian relaxation time (τ B) to increase, leading to a decrease in specific absorption rate (SAR). For colloidal conditions ensuring Brownian-dominated relaxation dynamics, an increase in MNP concentrations or medium viscosity is found to increase the τ B. SAR decreases with increasing MNP concentration, whereas it exhibits a non-monotonic variation with increasing medium viscosity. Dynamic hysteresis loop-based calculations are found to be in agreement with the experimental results. The findings provide a greater understanding of the variation of SAR with the colloidal properties and show the importance of relaxation dynamics on MFH efficiency, where variations in the frequency-relaxation time product across the relaxation plateau cause significant variations in SAR. Further, the in vitro cytotoxicity studies show good bio-compatibility of the chitosan-coated Fe3O4 MNPs. Higher SAR at acidic pH for bio-medically acceptable field parameters makes the bio-compatible chitosan-coated Fe3O4 MNPs suitable for MFH applications.

Dual Functional Magnetic Nanoparticles Conjugated with Carbon Quantum Dots for Hyperthermia and Photodynamic Therapy for Cancer.

The global incidence of cancer continues to rise, posing a significant public health concern. Although numerous cancer therapies exist, each has limitations and complications. The present study explores alternative cancer treatment approaches, combining hyperthermia and photodynamic therapy (PDT). Magnetic nanoparticles (MNPs) and amine-functionalized carbon quantum dots (A-CQDs) were synthesized separately and then covalently conjugated to form a single nanosystem for combinational therapy (M-CQDs). The successful conjugation was confirmed using zeta potential, Fourier transform infrared spectroscopy (FT-IR), and UV-visible spectroscopy. Morphological examination in transmission electron microscopy (TEM) further verified the conjugation of CQDs with MNPs. Energy dispersive X-ray spectroscopy (EDX) revealed that M-CQDs contain approximately 12 weight percentages of carbon. Hyperthermia studies showed that both MNP and M-CQDs maintain a constant therapeutic temperature at lower frequencies (260.84 kHz) with high specific absorption rates (SAR) of 118.11 and 95.04 W/g, respectively. In vitro studies demonstrated that MNPs, A-CQDs, and M-CQDs are non-toxic, and combinational therapy (PDT + hyperthermia) resulted in significantly lower cell viability (~4%) compared to individual therapies. Similar results were obtained with Hoechst and propidium iodide (PI) staining assays. Hence, the combination therapy of PDT and hyperthermia shows promise as a potential alternative to conventional therapies, and it could be further explored in combination with existing conventional treatments.

Fabrication and characterization of a novel magnetic nanostructure based on pectin-cellulose hydrogel for in vitro hyperthermia during cancer therapy.

Herein, a new magnetic nanobiocomposite based on a synthesized cross-linked pectin-cellulose hydrogel (cross-linked Pec-Cel hydrogel) substrate was designed and synthesized. The formation of the cross-linked Pec-Cel hydrogel with a calcium chloride agent and its magnetization process caused a new and efficient magnetic nanobiocomposite. Several spectral and analytical techniques, including FTIR, SEM, VSM, TGA, XRD, and EDX analyses, were performed to confirm and characterize the structural features of the magnetic cross-linked pectin-cellulose hydrogel nanobiocomposite (magnetic cross-linked Pec-Cel hydrogel nanobiocomposite). Based on SEM images, prepared Fe3O4 magnetic nanoparticles (MNPs) were uniformly dispersed in the Pec-Cel hydrogel context, representing an average particle size between 50.0 and 60.0 nm. The XRD pattern also confirms the crystallinity of the magnetic nanobiocomposite. All constituent elements and their distribution have been depicted in the EDX analysis of the magnetic nanobiocomposite. VSM curves confirmed the superparamagnetic behavior of Fe3O4 MNPs and the magnetic nanobiocomposite with a saturation magnetization of 77.31 emu g-1 and 48.80 emu g-1, respectively. The thermal stability of the nanobiocomposite was authenticated to ca. 800 °C based on the TGA thermogram. Apart from analyzing the structural properties of the magnetic cross-linked Pec-Cel hydrogel nanobiocomposite, different concentrations (0.5 mg mL-1, 1.0 mg mL-1, 2.0 mg mL-1, 5.0 mg mL-1, and 10.0 mg mL-1) of this new magnetic nanostructure were exposed to an alternating magnetic field (AMF) at different frequencies (100.0 MHz, 200.0 MHz, 300.0 MHz, and 400.0 MHz) to evaluate its capacity for an in vitro hyperthermia process; in addition, the highest specific absorption rate (126.0 W g-1) was obtained by the least magnetic nanobiocomposite concentration (0.5 mg mL-1).

Enhanced anti-tumor activity of transferrin/folate dual-targeting magnetic nanoparticles using chemo-thermo therapy on retinoblastoma cancer cells Y79

Malignant neoplasms are one of the main causes of death, especially in children, on a global scale, despite strenuous efforts made at advancing both diagnostic and therapeutic modalities. In this regard, a new nanocarrier Vincristine (VCR)-loaded Pluronic f127 polymer-coated magnetic nanoparticles conjugated with folic acid and transferrin (PMNP-VCR-FA-TF) were synthesized and characterized by various methods. The cytotoxicity of these nanoparticles was evaluated in vitro and ex vivo conditions. The in vitro anti-tumor effect of the nanoparticles was evaluated by colony formation assay (CFA) and reactive oxygen species (ROS) in Y79 cell line. The results showed that nanoparticles with two ligands conferred greater toxicity toward Y79 cancer cells than ARPE19 normal cells. Under an alternating magnetic field (AMF), these nanoparticles demonstrated a high specific absorption rate. The CFA and ROS results indicated that the AMF in combination with PMNP-VCR-FA-TF conferred the highest cytotoxicity toward Y79 cells compared with other groups (P < 0.05). PMNP-VCR-FA-TF could play an important role in converting externally applied radiofrequency energy into heat in cancer cells. The present study confirmed that dual targeting chemo-hyperthermia using PMNP-VCR-FA-TF was significantly more effective than hyperthermia or chemotherapy alone, providing a promising platform for precision drug delivery as an essential component in the chemotherapy of retinoblastoma.

Study of magnetic induction heating of Li0.25Zn0.3Co0.15Fe2.3O nanoparticles

Five different batches of Li0.25Zn0.3Co0.15Fe2.3O4 (LZC) nanoparticles were prepared by sol-gel method. Of these five batches, one has a very small mean size of ∼6.0 nm and the others have mean sizes of ∼11.9, 47.3, 114 and 139 nm. The phase formation of the nanoparticles is confirmed by analysing the X-ray diffraction (XRD) patterns using the Rietveld method. To ensure phase formation, further structural analyses, namely transmission electron microscopy, Raman spectroscopy and x-ray photoemission spectroscopy measurements are performed. Before analysing the magnetic properties of the prepared nanoparticles, Mössbauer spectra are recorded both at room temperature and at 77 K to determine the magnetic nature and hyperfine behaviour of the nanoparticles. The resence of magnetically blocked states is estimated by recording the dynamic hysteresis loops and then to gain insight into the magnetic properties of this particular Li-Zn-Co-ferrite stoichiometry, static M − H loops and field cooled and zero field cooled M-T curves are extracted using a vibrating sample magnetometer. Finally, the applicability of prepared nanoparticles as a heat mediator in magnetic induction heating is studied in an external field of 335 Oe intensity and 290 kHz frequency. The highest specific absorption rate (SAR) is found to be ∼212 W/gFerrite for 47.3 nm nanoparticles at a concentration of only 1 mg/mL.

Design and fabrication of a magnetic nanobiocomposite based on flaxseed mucilage hydrogel and silk fibroin for biomedical and in-vitro hyperthermia applications

In this research work, a magnetic nanobiocomposite is designed and presented based on the extraction of flaxseed mucilage hydrogel, silk fibroin (SF), and Fe3O4 magnetic nanoparticles (Fe3O4 MNPs). The physiochemical features of magnetic flaxseed mucilage hydrogel/SF nanobiocomposite are evaluated by FT-IR, EDX, FE-SEM, TEM, XRD, VSM, and TG technical analyses. In addition to chemical characterization, given its natural-based composition, the in-vitro cytotoxicity and hemolysis assays are studied and the results are considerable. Following the use of highest concentration of magnetic flaxseed mucilage hydrogel/SF nanobiocomposite (1.75 mg/mL) and the cell viability percentage of two different cell lines including normal HEK293T cells (95.73%, 96.19%) and breast cancer BT549 cells (87.32%, 86.9%) in 2 and 3 days, it can be inferred that this magnetic nanobiocomposite is biocompatible with HEK293T cells and can inhibit the growth of BT549 cell lines. Besides, observing less than 5% of hemolytic effect can confirm its hemocompatibility. Furthermore, the high specific absorption rate value (107.8 W/g) at 200 kHz is generated by a determined concentration of this nanobiocomposite (1 mg/mL). According to these biological assays, this magnetic responsive cytocompatible composite can be contemplated as a high-potent substrate for further biomedical applications like magnetic hyperthermia treatment and tissue engineering.

Enhanced magnetic hyperthermia efficiency in poly vinyl alcohol-coated zinc-substituted cobalt ferrite nanoparticles: Correlated effects of zinc content and applied magnetic field strength

Finding the interrelation among the magnetic response of the heat mediators to an alternating magnetic field (AMF) and other relevant parameters in magnetic hyperthermia therapy (MHT) can give the possibility to accurately design high-performance nanostructured magnetic nanoparticles (MNPs). In this context, the present work investigates the effect of the zinc substitution on magnetic properties and heat-generating ability of poly vinyl alcohol-coated Zn-substituted cobalt ferrite nanoparticles (PZC NPs) with different zinc contents (ZnxCo1−xFe2O4; x = 0, 0.15, 0.3, 0.4, 0.5, 0.7), synthesized using hydrothermal-assisted co-precipitation method. The obtained results showed that the PZC NPs with an average particle size ∼ 15 nm exhibit ferrimagnetic features and their coercivity (Hc) values decrease as the zinc content (x) increases. Moreover, as Zn2+ replaces Co2+ in the structure, saturation magnetization (Ms) increases up to about 52 emu/g for PZC-30 NPs (x =0.3) and then decreases for higher Zn contents. The hyperthermia measurements were performed at a fixed filed frequency (f=120kHz) and different magnetic field strengths (Happl=17,20,24.5kA/m). The results revealed that, as x increases, specific absorption rate (SAR) at each Happl first shows an increasing trend and then reaching a maximum value (at x=0.4) follows a decreasing trend. Moreover, the highest SAR (25.25 W/g) belongs to the magnetic fluid containing PZC-40 NPs at Happl=24.5kA/m. Furthermore, the Happl-dependency of the SAR values were obtained as a power law (SAR∼Happln) in which the exponent n rises as x decreases, suggesting that the optimal composition tends to shift to ones with the lower x at higher Happl. The obtained results, revealing the high impact of the interrelation between the chemical composition and the Happl on the MNPs heating efficiency, can shed more light on the way to design heat mediators with optimal performance through simultaneous control of the chemical composition and the Happl.

In vitro exposure of neuronal networks to the 5G-3.5 GHz signal.

The current deployment of the fifth generation (5G) of wireless communications raises new questions about the potential health effects of exposure to radiofrequency (RF) fields. So far, most of the established biological effects of RF have been known to be caused by heating. We previously reported inhibition of the spontaneous electrical activity of neuronal networks in vitro when exposed to 1.8 GHz signals at specific absorption rates (SAR) well above the guidelines. The present study aimed to assess the effects of RF fields at 3.5 GHz, one of the frequencies related to 5G, on neuronal activity in-vitro. Potential differences in the effects elicited by continuous-wave (CW) and 5G-modulated signals were also investigated. Spontaneous activity of neuronal cultures from embryonic cortices was recorded using 60-electrode multi-electrode arrays (MEAs) between 17 and 27 days in vitro. The neuronal cultures were subjected to 15 min RF exposures at SAR of 1, 3, and 28 W/kg. At SAR close to the guidelines (1 and 3 W/kg), we found no conclusive evidence that 3.5 GHz RF exposure impacts the activity of neurons in vitro. On the contrary, CW and 5G-modulated signals elicited a clear decrease in bursting and total firing rates during RF exposure at high SAR levels (28 W/kg). Our experimental findings extend our previous results, showing that RF, at 1.8 to 3.5 GHz, inhibits the electrical activity of neurons in vitro at levels above environmental standards.

Externally Applied Electromagnetic Fields and Hyperthermia Irreversibly Damage Cancer Cells

At present, the applications and efficacy of non-ionizing radiations (NIR) in oncotherapy are limited. In terms of potential combinations, the use of biocompatible magnetic nanoparticles as heat mediators has been extensively investigated. Nevertheless, developing more efficient heat nanomediators that may exhibit high specific absorption rates is still an unsolved problem. Our aim was to investigate if externally applied magnetic fields and a heat-inducing NIR affect tumor cell viability. To this end, under in vitro conditions, different human cancer cells (A2058 melanoma, AsPC1 pancreas carcinoma, MDA-MB-231 breast carcinoma) were treated with the combination of electromagnetic fields (EMFs, using solenoids) and hyperthermia (HT, using a thermostated bath). The effect of NIR was also studied in combination with standard chemotherapy and targeted therapy. An experimental device combining EMFs and high-intensity focused ultrasounds (HIFU)-induced HT was tested in vivo. EMFs (25 µT, 4 h) or HT (52 °C, 40 min) showed a limited effect on cancer cell viability in vitro. However, their combination decreased viability to approximately 16%, 50%, and 21% of control values in A2058, AsPC1, and MDA-MB-231 cells, respectively. Increased lysosomal permeability, release of cathepsins into the cytosol, and mitochondria-dependent activation of cell death are the underlying mechanisms. Cancer cells could be completely eliminated by combining EMFs, HT, and standard chemotherapy or EMFs, HT, and anti-Hsp70-targeted therapy. As a proof of concept, in vivo experiments performed in AsPC1 xenografts showed that a combination of EMFs, HIFU-induced HT, standard chemotherapy, and a lysosomal permeabilizer induces a complete cancer regression.